West Virginia Code of State Rules › Agency 5 - Dentistry, WV Board of › Title 5 - LEGISLATIVE RULE WEST VIRGINIA BOARD OF DENTISTRY › Series 5-10 - Practitioner Requirements for Accessing the West Virginia Controlled Substance Monitoring Program Database › Section 5-10-2 - Definitions

Current through Register Vol. XLI, No. 28, July 12, 2024
2.1. As used in
				this rule, the following words and terms have the following meaning:
2.1.a. "Administering" means the direct
				application of a drug to the body of a patient by injection, inhalation,
				ingestion or any other means.
2.1.b. "Authorized Agent" means an individual
				who is an employee of the practitioner permitted to have access to the CSMP
				repository and database who is specifically designated by the practitioner to
				access the database on his/her behalf.
2.1.c. "Benzodiazepine" means a class of
				controlled substance medications that produce sedation, induce sleep, relieve
				anxiety and prevent seizures and which are generally approved to treat anxiety
				disorder, insomnia, seizures, social phobia, and panic disorder.
2.1.d. "Board" means the West Virginia Board
				of Dentistry.
2.1.e. "Controlled
				substance" means a drug that is classified by federal or state law in Schedules
				I, II, III, IV, V as defined in W. Va. Code §
										60A-2-204 through 212.
2.1.f. "CSMP" means the West Virginia
				Controlled Substances Monitoring Program repository and database.
2.1.g. "DEA registration identification
				number" means the federal Drug Enforcement Administration registration
				identification number issued to a practitioner.
2.1.h. "Dispensing" means the preparation and
				delivery of a drug to an ultimate user by or pursuant to a lawful order of a
				practitioner, including the prescribing, packaging, labeling, administering or
				compounding necessary to prepare the drug for that delivery.
2.1.i. "Medical records" means records
				including the medical history and physical examination; diagnostic, therapeutic
				and laboratory results; evaluations and consultations; treatment objectives;
				discussion of risks and benefits; informed consent; treatments; medications
				(including date, type, dosage and quantity provided); instructions and
				agreements; and periodic reviews.
2.1.j. "Opioid" means natural and
				semi-synthetic derivatives of the opium poppy, as well as similar synthetic
				compounds that have analgesic or pain relieving properties because of their
				effects in the central nervous system. These include, but are not limited to,
				codeine, morphine, hydromorphone, hydrocodone, oxycodone, methadone, and
				fentanyl.
2.1.k. "Patient" means a
				person presenting himself or herself for treatment who is not considered by the
				practitioner as suffering from a terminal illness.
2.1.l. "Practitioner" means a dentist
				licensed pursuant to the provisions of the West Virginia Dental Practice Act,
				W. Va. Code §
										30-4-1 et seq. who possesses a
				valid DEA registration identification number.
2.1.m. "Providing" means
				prescribing
,
dispensing or administering
				medication.
2.1.n. "Terminal
				illness" means an incurable or irreversible condition as diagnosed by the
				attending physician or a qualified physician for which the administration of
				life-prolonging intervention will serve only to prolong the dying
				process.